ロード中...
Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
Background: Denosumab is a RANK-l inhibitor that, in addition to the treatment of osteoporosis, is used in patients with advanced cancer and metastatic bone disease to prevent skeletal-related events. Although denosumab is generally safe and effective, it can cause hypocalcemia which in some patient...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089690/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.385 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|